Close Menu

A Dow Jones Newswires story covers personalized medicine with profiles of companies, including Sequenom and Helicos, that push diagnostic tests for biomarkers. It's the expected growth in this arena that led to Invitrogen's $6.7 billion acquisition of Applied Biosystems, the article says; more deals are likely in the offing. The story quotes analyst Arthur Henderson as saying, "There is a lot of competition for deals; it is going to increase. ... The sky is the limit in terms of opportunity."

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Howard Hughes Medical Institute will be requiring its researchers to publish their work so it is immediately accessible to the public, ScienceInsider writes.

The Huffington Post reports that Francis Collins, the director of the US National Institutes of Health, has urged Americans to recommit to reason.

About 150 million rapid coronavirus tests purchased by the US federal government are to be distributed to nursing homes, colleges, and the states, according to the New York Times.

In Nature this week: multi-omic analysis of Alzheimer's disease brain samples, de novo assembly of a diploid potato, and more.